Equities

Advanced Medical Solutions Group PLC

Advanced Medical Solutions Group PLC

Actions
  • Price (GBX)242.35
  • Today's Change-5.65 / -2.28%
  • Shares traded6.34k
  • 1 Year change-7.32%
  • Beta0.8514
Data delayed at least 15 minutes, as of Dec 01 2020 15:12 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Advanced Medical Solutions Group plc is engaged in the design, development, manufacture and distribution of materials for use in advanced woundcare products and surgical dressings, as well as medical adhesives and sutures for closing and sealing tissue. It operates through four segments: Branded Direct, Branded Distributed, OEM (Original Equipment Manufacturer) and Bulk Materials. Its Branded Direct segment is engaged in selling, marketing and innovation of its branded products sold directly by its sales teams. Its Branded Distributed segment is engaged in distribution, marketing and innovation of its brands sold by distributors in markets not serviced by its sales team. Its OEM segment is engaged in selling, marketing and innovation of its products supplied to partners under their brands. Its Bulk Materials segment is engaged in selling, marketing and innovation of bulk materials to medical device partners and convertors. Its products include ActivHeal, LiquiBand and RESORBA.

  • Revenue in GBP (TTM)92.94m
  • Net income in GBP13.79m
  • Incorporated1993
  • Employees700.00
  • Location
    Advanced Medical Solutions Group PLCPremier Park, 33 Road OneWINSFORD CW7 3RTUnited KingdomGBR
  • Phone+44 160 686 3500
  • Fax+44 160 686 3600
  • Websitehttps://www.admedsol.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
AMS:LSE since
announced
Transaction
value
Biomatlante SADeal completed02 Dec 201902 Dec 2019Deal completed-6.70%8.81m
Data delayed at least 20 minutes, as of Dec 01 2020 16:35 GMT.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.